Introduction
Reconstruction of peripheral nerve defects remains a great challenge for surgeons. Nerve autografts are considered the golden standard for clinical treatments in repairing large lesion gaps in the peripheral nervous system; the disadvantages include limited availability of donor nerves and donor site morbidity (1) (2) (3) . Therefore, intensive research has been focused on artificial nerves. However, obtaining an adequate number of autologous Schwann cells for constructing artificial nerves requires much time, which contributes to delaying repair of the peripheral nerve injuries and has a negative impact on nerve regeneration. As for allogeneic Schwann cells, immunological rejection remains a problem when contributing to construction of artificial nerves (4) (5) (6) .
Schwann cells contribute to immunogenicity of artificial nerve via expressing major histocompatibility complex (MHC) I and MHC II antigens (7, 8) . Immunosuppressive agents have been applied to prolong the survival of Schwann cells; however, it has been found that there was extensive loss of regenerated axons in the allograft when immunosuppression was withdrawn (9) . Mosahebi et al. (4) demonstrated that the increase of expression of MHC II at 3 weeks in the conduits containing allogeneic Schwann cells corresponded to an increase of infiltration of T-lymphocytes as well as macrophages. Furthermore, there was a corresponding reduction in X-gal staining at 3 weeks pointing to a rejection process of allogeneic Schwann cells. Therefore, downregulation of the MHC II gene is important for survival of Schwann cells.
Class II transactivator (CIITA) is referred to as a chief regulator of MHC II transcription (10) . It is also important for both constitutive expression of MHC II in B-cells or dendritic cells as well as cytokine-induced expression of MHC-II in a variety of other cell types including fibroblasts and vascular endothelial cells. Recent research (11) showed that disruption of function of CIITA played a beneficial role in preventing normal allogeneic T-cell responses and thus can prolong survival of CIITA-deficient hearts as compared to wild-type grafts. Therefore, we believe that CIITA is a potential target gene to downregulate immunogenicity of Schwann cells. The aim of the present study is to investigate the feasibility of downregulating immunogenicity of Schwann cells via inhibiting a potential target of the CIITA gene, which might contribute to suppress immunological rejection of allogeneic Schwann cells.
Material and Methods

Cell lines and cell culture
The rat RSC96 Schwann cells were purchased from the Cell Bank of Chinese Academy of Science (Shanghai, China). Schwann cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) (Gibco, Life Technologies, Carlsbad, CA, USA), with 4 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 90% 4.5 g/L glucose and 10% fetal bovine serum, at 37°C in a humidified incubator with 5% CO 2 .
Construction of siRNA expression vectors
According to the recommendations of Ambion (Life Technologies) and Genscript (GenScript, Piscataway, NJ, USA) on the RNAi target sequence, ten pairs of DNA oligonucleotides were designed and synthesized for hairpin RNA expression by Sangon (Shanghai, China) ( Table 1) . Oligonucleotides were dissolved in sterile, nuclease-free H 2 O to a concentration of 3 mg/mL, and kept at −20°C. Oligonucletides were subsequently assembled using an annealing reaction by mixing 1 μL of each oligonucleotide (sense + antisense) with 48 μL annealing buffer. The mixture was incubated at 90°C for 4 min, at 70°C for additional 10 min, and then was slowly cooled to 10°C.
To linearize 1 μL of the pSUPER vector with Bgl II and Hind III restriction enzymes, oligonucleotides were inserted into the linearized pSUPER vectors at a molar ratio of 3:1 with the aid of T4 DNA ligase. Colonies were picked randomly. Then the recombinant plasmids were transformed into Top10F competent cells (Novegen, Darmstadt, Germany). The plasmids were extracted and purified, and digested with Eco RI and Hind III to confirm the presence of insert.
Vectors transfected into rat Schwann cells
The RSC96 cells were plated at a density of 2 × 10 
was 10 6 cells/100 μL. PBMCs and stimulative cells were mixed and cultured for 3 days. Then mononuclear cell proliferation was detected by MTT assay. Briefly, 20 μL of MTT (Sigma-Aldrich, St. Louis, MO, USA) at 5 mg/mL was added into each well and incubated for 4 h in a 37°C, 5% CO 2 and 90% humidity incubator. The medium was then removed and 150 μL DMSO (Fisher Scientific, Loughborough, UK) was added to each well to extract and solubilize the formazan crystal by incubating for 10 min. Finally, the plate was read at 570 nm using a microplate photometer (Multiskan Ascent, Thermo Fisher Scientific, Waltham, MA, USA).
Statistical analysis
Data are displayed as mean ± SD, SPSS 11.5 (SPSS Inc., Chicago, IL, USA) and one-way analysis of variance (ANOVA) tests were used for statistical analysis. p < 0.05 was considered statistically significant.
Results
CIITA and MHC II mRNA expression after siRNA transfection
The mRNA level of CIITA and MHC II were measured by fluorescence quantitative PCR. IFN-γ treatment of Schwann cells elevated the expression of CIITA and MHC II genes. Forty eight hours after transfection, the mRNA level of CIITA and MHC II were significantly decreased in all siRNA groups, compared to the control group (Table 2) . However, the difference between non-specific vector controls and the negative control group was not significant (p > 0.05). Among the four siRNA groups, the siRNA group 2 was the most efficient, mRNA levels of CIITA and MHCII decreased by an average of 88.32 ± 0.93% and 86.54 ± 0.69%, respectively. Thus we chose siRNA 2 as interference vector in the subsequent experiments.
MHC II protein expression after siRNA transfection
The effect of transfection on MHC II expression on Schwann cells was assessed by flow cytometry. Results are shown in Table 3 . The expression of MHC II of Schwann cells was at a low level without IFN-γ treatment, however, the expression of MHC II increased significantly after exposure to IFN-γ. Forty eight hours after transfection, the protein expression of MHC II was decreased significantly compared to the control group (p < 0.01). 
Mixed lymphocyte reaction
Fluorescence quantitative PCR
Total RNA of the cells was isolated and collected with RNase-free DNase Set (Qiagen, Valencia, CA, USA). RT-PCR was performed using the RNA PCR kit (TaKaRa, Ver.3.0) and employing 0.4 mg total RNA as the template per time point. For CIITA mRNA amplification, the primers 5'-GCCTGAGATGACCC TGCTGTA-3' and 5'-CAGTTCAAGGTCCAGCATG GT-3' were used. For MHC II mRNA amplification, the primers 5'-GCATACGGCTCGTGATCAGA-3' and 5'-CCCACGTCGCTGTCGAA-3' were used. Cycling conditions were as follows: 90 sec at 95°C; followed by 40 cycles of 5 sec at 95°C, 30 sec at 58°C, and 1 min at 95°C, 1 min at 58°C; a touchdown (0.5°C/cycle) annealing for 10 sec, with the last cycle concluding with a reaction for 7 min at 72°C. The obtained PCR products were separated using 1.5% agarose gel electrophoresis, analyzed by AlphaImager 2000 (Alpha Innotech Corporation, San Leandro, CA, USA), and quantitated by a digitalized software (Kodak Digital Science™ ID Image Analysis Software; Eastman Kodak Co., Rochester, NY, USA).
Flow cytometry
RSC96 Schwann cells were collected and washed in phosphate buffered saline (PBS); cell concentration was adjusted to 5 × 10 6 -1 × 10 7 /mL. Cells were stained with specific MHC II antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA), and then washed with PBS. After washing, the cells were stained with goat anti-rat fluorescent antibody, and fixed in 10 mL of ice-cold 75% ethanol. After 24 h of incubation at 20°C, cells were washed twice in PBS and resuspended in 3 mL of PBS for 5 min. Three-color flow cytometry was employed using an Enzymatic Amplification Staining Kit (Flow-Amp Systems, Tebu-bio, Le Perray en Yvelines, France) (12).
Mixed lymphocytes reaction
Normal peripheral blood mononuclear cells (PBMCs) were isolated from heparinized, vacutainer-collected peripheral blood using Ficoll-Hypaque density gradient centrifugation at 2,000 rpm for 10 min. 
Discussion
Schwann cells are critical for nerve regeneration, and are the major cells contributing to the immunological rejection of nerve allografts because of MHC expression (13) . Schwann cells can act as nonprofessional antigen presenting cells (APC) under certain conditions, and can activate T cells in vitro in an antigen-specific and MHC-restricted manner (14, 15) . Allogeneic Schwann cells seem to induce the upregulation of inflammatory cytokines such as IFN-γ, which are known to participate in immunological rejection. The authors have observed low level expression of MHC II molecules on cultured rat Schwann cells, and the present study confirmed that rat Schwann cells can be induced by IFN-γ to express a high level of MHC II molecules.
The expression of classical and nonclassical MHC II genes is regulated primarily by CIITA (10), which is achieved by three independent CIITA promoters (pI, pIII, and pIV), promoter pIV can be activated by IFN-γ. CIITA is the chief regulator of MHC II gene transcription and MHC II-restricted antigen presentation. The present study confirmed that there was a clear correlation between MHC II genes and the CIITA gene, the expression of MHC II molecules and the CIITA gene on Schwann cells increased simultaneously followed by IFN-γ induction. The CIITA gene is an ideal target for inhibiting the expression of MHC II genes.
RNA interference can inhibit the expression of the CIITA gene. In the present study, the pSUPER plasmid was used as the vector. The plasmid contained the RNA polymerase III H1 promoter, and could transcribe the hairpin RNA with a 9-nt stem-loop structure which can produce the target sequence. After transfection with pSUPER recombinant vectors (16), the induced MHC II expression on cell surface was significantly inhibited, and the CIITA mRNA level was also decreased. The expression of CIITA and MHC II were significantly inhibited after transfection for 48 h, indicating that 48 h was the optimal time for RNA interference. We also found that the inhibitory degree of MHC II gene expression was lower than that of the CIITA gene; therefore, we speculated that the MHC II gene may be also regulated by an additional regulation approach except for CIITA. Mixed lymphocyte reaction is an assay to detect response of alloreactive T cells to foreign MHC molecules and is used as a predictive test for T cellmediated graft rejection (17) (18) (19) (20) . In the present study, a one-way mixed lymphocyte reaction was applied. PBMCs were used as reaction cells, and Schwann cells were used as stimulative cells. Alloantigen recognition of mixed lymphocyte reaction in vitro occurs via a direct recognition pathway, which plays a dominant role in acute rejection. The results of mixed lymphocyte assays demonstrated that the immunogenicity of rat Schwann cells increased after exposure to IFN-γ, and there was a decline in the immunogenicity after 48 h of transfection, which confirmed that the immunogenicity of Schwann cells depended on the expression of MHC II molecules. In direct recognition, alloreactive T cells are stimulated by donor APCs which express the allogeneic MHC, however, in the present study, PBMCs were stimulated successfully without the existence of any professional donor APCs. Therefore, we believethat Schwann cells may be able to take up antigens and act as non-professional APCs with IFN-γ treatment.
In conclusion, the pSUPER recombinant vectors targeting the CIITA gene can specifically suppress gene expression of CIITA and MHC II and thus significantly downregulate the immunogenicity of rat Schwann cells in vitro. Further experimentation will be needed to determine whether the decline in the immunogenicity of Schwann cells can be sustained. 
